KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 75 filers reported holding KALA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $5,551,000 | -42.2% | 1,458,770 | -3.2% | 0.00% | -50.0% |
| Q2 2019 | $9,611,000 | -25.3% | 1,506,499 | -3.1% | 0.00% | -33.3% |
| Q1 2019 | $12,860,000 | +72.4% | 1,555,177 | +1.9% | 0.00% | +50.0% |
| Q4 2018 | $7,460,000 | -52.2% | 1,525,643 | -3.6% | 0.00% | -33.3% |
| Q3 2018 | $15,621,000 | -50.0% | 1,582,727 | -30.4% | 0.00% | -57.1% |
| Q2 2018 | $31,215,000 | -23.2% | 2,273,526 | -11.4% | 0.01% | -22.2% |
| Q1 2018 | $40,625,000 | -36.0% | 2,566,323 | -25.2% | 0.01% | -35.7% |
| Q4 2017 | $63,475,000 | -17.8% | 3,432,955 | +1.2% | 0.01% | -22.2% |
| Q3 2017 | $77,251,000 | – | 3,391,322 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 1 | $9 | 0.00% |